Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer[Formula presented]

Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, Adam C. Reese, Michael J. Biles, Kelly T. Harris, George Netto, Andres Matoso, Jean Hoffman-Censits, Noah M. Hahn, Woonyoung Choi, David McConkey, Phillip M. Pierorazio, Michael H. Johnson, Mark P. Schoenberg, Max R. Kates, Alex Baras, Trinity J. Bivalacqua

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer[Formula presented]'. Together they form a unique fingerprint.

Medicine & Life Sciences